These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15614831)

  • 1. Transdermal delivery of imipramine hydrochloride: development and evaluation (in vitro and in vivo) of reservoir gel formulation.
    Jain AK; Panchagnula R
    Biopharm Drug Dispos; 2005 Mar; 26(2):41-9. PubMed ID: 15614831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single and multiple dose pharmacokinetic evaluation of a transdermal delivery system of imipramine hydrochloride.
    Panchagnula R; Dravid P; Jain A; Khandavilli S
    Arzneimittelforschung; 2005; 55(4):198-204. PubMed ID: 15901042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
    Shah DK; Khandavilli S; Panchagnula R
    Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes.
    Jain AK; Thomas NS; Panchagnula R
    J Control Release; 2002 Feb; 79(1-3):93-101. PubMed ID: 11853921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
    J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R; Bokalial R; Sharma P; Khandavilli S
    Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
    Babu RJ; Pandit JK
    Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of limonene-based transdermal therapeutic system of nicorandil in healthy human volunteers.
    Krishnaiah YS; Chandrasekhar DV; Rama B; Jayaram B; Satyanarayana V; Al-Saidan SM
    Skin Pharmacol Physiol; 2005; 18(6):263-72. PubMed ID: 16113596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal permeation of trimetazidine from nerodilol-based HPMC gel drug reservoir system across rat epidermis.
    Krishnaiah YS; Al-Saidan SM
    Med Princ Pract; 2008; 17(1):37-42. PubMed ID: 18059099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketorolac tromethamine transdermal gel: development, in vitro and in vivo evaluation.
    Dubey R; Bommagani M; Venkateswarlu V; Mullangi R; Karnati HR; Thammera RK; Menon VC
    J Pain Palliat Care Pharmacother; 2009; 23(1):26-34. PubMed ID: 19296352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the loratadine gel for enhanced transdermal delivery.
    Song JH; Shin SC
    Drug Dev Ind Pharm; 2009 Aug; 35(8):897-903. PubMed ID: 19241201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
    Mutalik S; Udupa N
    J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal drug delivery of tricyclic antidepressants: effect of fatty acids.
    Jain AK; Panchagnula R
    Methods Find Exp Clin Pharmacol; 2003; 25(6):413-21. PubMed ID: 12949625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine.
    Baboota S; Shakeel F; Kohli K
    Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):109-14. PubMed ID: 16636721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration-enhancing effect of ethanolic solution of menthol on transdermal permeation of ondansetron hydrochloride across rat epidermis.
    Krishnaiah YS; Kumar MS; Raju V; Lakshmi M; Rama B
    Drug Deliv; 2008 May; 15(4):227-34. PubMed ID: 18446568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.
    Krishnaiah YS; Rama B; Raghumurthy V; Ramanamurthy KV; Satyanarayana V
    Pharm Dev Technol; 2009; 14(1):50-61. PubMed ID: 18819031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal delivery of imipramine and doxepin from newly oil-in-water nanoemulsions for an analgesic and anti-allodynic activity: development, characterization and in vivo evaluation.
    Sandig AG; Campmany AC; Campos FF; Villena MJ; Naveros BC
    Colloids Surf B Biointerfaces; 2013 Mar; 103():558-65. PubMed ID: 23261580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
    Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
    Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.